Journal
ANAEROBE
Volume 6, Issue 4, Pages 227-231Publisher
ACADEMIC PRESS LTD
DOI: 10.1006/anae.2000.0348
Keywords
-
Categories
Ask authors/readers for more resources
The activity of moxifloxacin (BAY 12-8039), a new 8-methoxyquinolone, was determined using the NCCLS-approved Wadsworth brucella laked blood agar method and compared to the activities of metronidazole, penicillin G, piperacillin/tazobactam and trovafloxacin. Breakpoints used to define susceptible and resistant categories were, respectively: less than or equal to 8 and greater than or equal to 32 mu g/mL for metronidazole, less than or equal to 2 and greater than or equal to 8 mu g/mL for moxifloxacin and trovafloxacin, less than or equal to 0.5 and greater than or equal to 2 mu g/mL for penicillin G and less than or equal to 32 and greater than or equal to 128 mu g/mL for piperacillin/tazobactam. A total of 179 anaerobic isolates from pulmonary infections were tested. Piperacillin/tazobactam was the most active antimicrobial, inhibiting 99% of strains at the susceptible breakpoint. Ninety-seven percent of these isolates were susceptible to moxifloxacin; 96% to trovafloxacin, 89% to metronidazole and 43% to penicillin G. Geometric mean moxifloxacin MIC values for Bacteroides fragilis and the B. fragilis group were 0.5 and 0.8 mu g/mL, respectively. Eighty-eight percent of B, fragilis and 100% of other B. fragilis group species were susceptible to both moxifloxacin and trovafloxacin. All of the strains of B. fragilis and most of the other B. fragilis group species were resistant to penicillin G. At least 99% of other Bacteroides species, Prevotella, and Fusobacterium strains were susceptible to moxifloxacin, metronidazole, piperacillin/tazobactam and trovafloxacin (88% were susceptible to trovafloxacin at 2 mu g/mL and all were susceptible at 4 mu g/mL). The strains of Clostridium difficile and Clostridium ramosum found in these specimens were both resistant to penicillin G but susceptible to the other agents. All strains of Peptostreptococcus species were susceptible to all of the agents except penicillin G. Activities of the agents against non-spore-forming Gram-positive rods at the intermediate breakpoint were, respectively, moxifloxacin-100%, metronidazole-49%, penicillin G-86%, piperacillin/tazobactam-100%, and trovafloxacin-97%. The promising in vitro activity of moxifloxacin against anaerobic pulmonary isolates warrants further investigation, including clinical correlation studies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available